Background Recent studies have suggested a possible association between pneumonia
and the use of inhaled corticosteroids. We aimed to ascertain the risk of pneumonia with …

Clinicians should consider the long-term risks of pneumonia with the use of inhaled
corticosteroids in patients with COPD. Adequately powered long-term head-to-head trials …

Background The use of inhaled corticosteroids in patients with chronic obstructive
pulmonary disease (COPD) has been associated with an increased risk of pneumonia in …

Rationale: Inhaled corticosteroids are commonly prescribed to patients with chronic
obstructive pulmonary disease (COPD). Objectives: To examine whether these medications …

Observational studies of inhaled corticosteroids in chronic obstructive pulmonary disease
(COPD) have shown improved survival whereas randomized trials have not. It has been …

PURPOSE: Although inhaled corticosteroids are commonly used to treat patients with
chronic obstructive pulmonary disease (COPD), their effect on clinical outcomes such as …

Rationale: Treatment with inhaled corticosteroids (ICS) for those with chronic obstructive
pulmonary disease (COPD) has been shown to be associated with an increased incidence …

Recent studies suggest that use of inhaled corticosteroids (ICS) in chronic obstructive
pulmonary disease (COPD) may be associated with a higher incidence of pneumonia …

Objective Inhaled corticosteroids (ICS) are generally used to treat patients with chronic
obstructive pulmonary disease (COPD) who suffer from repeated exacerbations. Recently, it …

Recent data suggest that inhaled corticosteroids reduce the number of clinical
exacerbations in chronic obstructive pulmonary disease (COPD). It remains unknown …